Synovus Financial’s Clearside Biomedical CLSD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$24K	Hold	30,000	–	–	﹤0.01%	907
2025 Q1	$27.5K	Hold	30,000	–	–	﹤0.01%	890
2024 Q4	$28.5K	Sell	30,000 -23,071	-43%	-$21.9K	﹤0.01%	871
2024 Q3	$67.4K	Hold	53,071	–	–	﹤0.01%	903
2024 Q2	$69K	Hold	53,071	–	–	﹤0.01%	833
2024 Q1	$81.2K	Hold	53,071	–	–	﹤0.01%	835
2023 Q4	$62.1K	Sell	53,071 -5,000	-9%	-$5.85K	﹤0.01%	814
2023 Q3	$50.5K	Hold	58,071	–	–	﹤0.01%	827
2023 Q2	$65K	Hold	58,071	–	–	﹤0.01%	828
2023 Q1	$60.4K	Sell	58,071 -6,780	-10%	-$7.05K	﹤0.01%	812
2022 Q4	$72.6K	Hold	64,851	–	–	﹤0.01%	843
2022 Q3	$74K	Hold	64,851	–	–	﹤0.01%	829
2022 Q2	$95K	Sell	64,851 -10,000	-13%	-$14.6K	﹤0.01%	825
2022 Q1	$171K	Buy	74,851 +46,780	+167%	+$107K	﹤0.01%	820
2021 Q4	$77K	Hold	28,071	–	–	﹤0.01%	847
2021 Q3	$168K	Hold	28,071	–	–	﹤0.01%	815
2021 Q2	$136K	Hold	28,071	–	–	﹤0.01%	818
2021 Q1	$69K	Hold	28,071	–	–	﹤0.01%	741
2020 Q4	$77K	Buy	+28,071	New	+$77K	﹤0.01%	751
2019 Q4	–	Sell	-5,000	Closed	-$3K	–	1552
2019 Q3	$3K	Hold	5,000	–	–	﹤0.01%	1343
2019 Q2	$5K	Hold	5,000	–	–	﹤0.01%	1212
2019 Q1	$7K	Hold	5,000	–	–	﹤0.01%	1167
2018 Q4	$5K	Sell	5,000 -500	-9%	-$500	﹤0.01%	1191
2018 Q3	$34K	Hold	5,500	–	–	﹤0.01%	914
2018 Q2	$59K	Hold	5,500	–	–	﹤0.01%	758
2018 Q1	$59K	Buy	+5,500	New	+$59K	﹤0.01%	745
2017 Q2	–	Sell	-3,500	Closed	-$28K	–	841
2017 Q1	$28K	Buy	3,500 +2,000	+133%	+$16K	﹤0.01%	807
2016 Q4	$13K	Buy	+1,500	New	+$13K	﹤0.01%	886